Acute Repetitive Seizures Market, By Drug Type (Benzodiazepines, Antiepileptic drugs, Barbiturates, Others), By Route of Administration (Oral, Injectable, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geo
Acute Repetitive Seizures Market, By Drug Type (Benzodiazepines, Antiepileptic drugs, Barbiturates, Others), By Route of Administration (Oral, Injectable, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
Acute repetitive seizures (ARS) are characterized by two or more unprovoked seizures occurring within a 24-hour period without restoration of consciousness between the seizures. Acute repetitive seizures contributes significantly to the disease burden among epileptic patients. Factors contributing to increase in ARS cases globally includes growing geriatric population prone to seizures and increasing prevalence of epilepsies arising from strokes, brain injuries, and neuroinfectious. However, advancements in ARS treatment options such as newer generation anticonvulsants and dedicated emergency treatment protocols in hospitals are expected to aid patients and drive the market growth in the near future.
Market Dynamics:
Global acute repetitive seizures market growth is p driven by increasing incidence of epilepsy worldwide. It is estimated that 50 million people suffer from epilepsy globally. Furthermore, rising geriatric population susceptible to neurological disorders, strokes, and brain injuries leading to seizures boosts demand for acute repetitive seizures treatment over the forecast period. However, high costs of emergency care and unmet medical needs in low-income regions can hamper the market growth. Development of inexpensive generic anticonvulsants provides opportunities for the market growth. Initiatives aimed at raising awareness about timely identification and treatment of ARS can reduce mortality and disability rates.
Key Features of the Study:
This report provides an in-depth analysis of the global acute repetitive seizures market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global acute repetitive seizures market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes Neurelis, Inc., Bausch Health Companies Inc., Alexza Pharmaceuticals, Inc., VERITON PHARMA, UCB S.A., Takeda Pharmaceutical Company Limited, Pfizer Inc., Sanofi, GSK plc, Eisai Co., Ltd., H. Lundbeck A/S, Cognizance Biomarkers, LLC.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global acute repetitive seizures market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global acute repetitive seizures market.
Detailed Segmentation-
By Drug Type:
Benzodiazepines
Antiepileptic drugs
Barbiturates
Others (Late Phase Drugs, etc.)
By Route of Administration:
Oral
Injectable
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region:
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
Company Profiles:
Neurelis, Inc.
Bausch Health Companies Inc.
Alexza Pharmaceuticals, Inc.
VERITON PHARMA
UCB S.A.
Takeda Pharmaceutical Company Limited
Pfizer Inc.
Sanofi
GSK plc
Eisai Co., Ltd.
Lundbeck A/S
Cognizance Biomarkers, LLC
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Drug Type
Market Snapshot, By Route of Administration
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter’s Analysis
4. Global Acute Repetitive Seizures Market - Impact of Coronavirus (COVID-19) Pandemic
Overall Impact
Government Initiatives
COVID-19 Impact on the Market
5. Global Acute Repetitive Seizures Market, By Drug Type, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends
Benzodiazepines
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Antiepileptic drugs
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Barbiturates
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Others (Late Phase Drugs, etc.)
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
6. Global Acute Repetitive Seizures Market, By Route of Administration, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends
Oral
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Injectable
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
7. Global Acute Repetitive Seizures Market, By Distribution Channel, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends
Hospital Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Retail Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Online Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
8. Global Acute Repetitive Seizures Market, By Region, 2019 – 2031, (USD Bn)
Introduction
Market Share Analysis, By Region, 2024 and 2031 (%)
Y-o-Y Growth Analysis, For Region, 2020–2031
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Bn)
North Africa
Central Africa
South Africa
9. Competitive Landscape
Company Profiles
Neurelis, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Bausch Health Companies Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Alexza Pharmaceuticals, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
VERITON PHARMA
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
UCB S.A.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Takeda Pharmaceutical Company Limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Pfizer Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Sanofi
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
GSK plc
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Eisai Co., Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
H. Lundbeck A/S
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Cognizance Biomarkers, LLC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
10. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
11. References and Research Methodology
References
Research Methodology
About us and Sales Contact
*Browse 28 market data tables and 25 figures on "Acute Repetitive Seizures Market” - Global forecast to 2031